STRS Ohio
JANX icon

STRS Ohio’s Janux Therapeutics JANX Stock Holding History

STRS Ohio’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.7K Buy
+2,300
New +$38.6K ﹤0.01% 2082
2025
Q1 		– Sell
-4,600
Closed -$246K – 1972
2024
Q4 		$246K Buy
4,600
+2,700
+142% +$143K ﹤0.01% 1434
2024
Q3 		$86.3K Buy
+1,900
New +$82.7K ﹤0.01% 1732
2021
Q4 		– Sell
-3,000
Closed -$64K – 2254
2021
Q3 		$64K Buy
+3,000
New +$86.3K ﹤0.01% 2026

Other funds holding JANX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Jackson Creek Investment Advisors
Jackson Creek Investment Advisors Castle Rock, Colorado $292M AUM 56.98% 1-Year Est. Return

STRS Ohio's JANX Position: Q3 2026 in Review

STRS Ohio opened a new position in Janux Therapeutics (JANX) in Q3 2026: 2,300 shares worth $39.7K. The stake represents ﹤0.01% of the portfolio and ranks #2082 among its holdings. This is a return to the name: STRS Ohio previously reported a position in JANX as recently as Q4 2024.

STRS Ohio first reported a position in JANX in Q3 2021 and has held it in 4 quarters since. The position peaked at $246K in Q4 2024. 58 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • STRS Ohio held 2,300 shares of Janux Therapeutics worth $39.7K as of Q3 2026.
  • Janux Therapeutics was a new STRS Ohio position in Q3 2026.
  • Janux Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2082 holding.
  • STRS Ohio first reported a position in Janux Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • STRS Ohio's Janux Therapeutics position peaked at $246K in Q4 2024.
  • 58 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.